Clinical Information
Selecting and combining THERA Nordic products: a clinical reference
For healthcare professionals. This content is intended for practitioners only.
This article is a clinical reference for the THERA Nordic range. For each product it sets out what the product contai...
REZCUE
REZCUE — Clinical Application Protocols and Intervention Dosing
This article is based on our REZCUE white paper which you can download here.
REZCUE combines two well-researched gut mucosal agents: pharmaceutical-grade Zinc L-Carnosine (37.5mg per scoop) and L...
White Papers
Zinc Carnosine and L-Glutamine in Radiation-Induced Mucositis: A Clinician Briefing
Oral mucositis is one of the most treatment-limiting toxicities in head and neck radiotherapy. Beyond pain and quality of life, prolonged overall treatment time is linked to poorer locoregional con...
REZCUE
REZCUE: Mucosal Protection During NSAID Use
NSAIDs damage the gut through two separate mechanisms: prostaglandin-mediated loss of mucosal defences (acid-driven, addressed by PPIs) and direct cytotoxic injury to the small intestine (acid-inde...
Case Studies
Zinc L-Carnosine and Atrophic Gastritis: What a New Case Series Actually Shows
A November 2025 case series reported that two patients with chronic atrophic gastritis (CAG) — one post-H. pylori, one autoimmune — showed histological improvement after 12 months on zinc L-carnosi...